DRIO · DarioHealth Corp. · Documents

$2.38 -0.35 (-12.84%) At close · Nov 6 Q1 2026 earnings call transcript

Market Cap

$23.27M

9.80M

Volume · Nov 6 14.9K Avg daily vol (3M) 38.18K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024

Dec 31

Earnings call

Q4 2024 earnings call

Dec 18

Current report 8-K

Shareholder vote results

Dec 18

Current report 8-K Events of Dec 16

Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity, Other events

Nov 7

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $7.42M ▲ 111.0% Net loss $12.33M Diluted EPS $0.25 ▼ 49.0%

Oct 24

Proxy statement DEF 14A Meeting Dec 18, 2024

Proxy statement

Sep 30

Earnings call

Q3 2024 earnings call

Sep 20

Current report 8-K Events of Sep 16

Delisting notice or listing transfer

Sep 13

Current report 8-K Events of Sep 11

Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change

Aug 8

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $6.26M ▲ 1.7% Net loss $13.61M Diluted EPS $0.08 ▼ 86.2%

Jun 30

Earnings call

Q2 2024 earnings call

Jun 28

Current report 8-K Events of Jun 25

Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change

Jun 25

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results

Jun 5

Current report 8-K

Director or officer change, or executive pay

May 15

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $5.76M ▼ 18.5% Net loss $7.18M Diluted EPS $0.20 ▼ 55.6%

May 3

Registration statement S-3/A

Registration statement

May 1

Proxy statement DEF 14A Meeting Jun 25, 2024

Proxy statement

Apr 22

Current report 8-K Events of Feb 15

Completed an acquisition or sale of assets

Apr 22

Registration statement S-3

Registration statement

Apr 19

Current report 8-K Events of Apr 16

Charter or bylaw amendment, or fiscal year change

Apr 19

Proxy statement PRE 14A Meeting Jun 25, 2024

Proxy statement

Apr 5

Current report 8-K Events of Apr 4

Director or officer change, or executive pay

Mar 31

Earnings call

Q1 2024 earnings call

Mar 28

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $20.35M ▼ 26.4% Net loss $59.43M Diluted EPS $1.93 ▼ 24.0%

Mar 1

Current report 8-K

Other events

Feb 22

Current report 8-K

Regulation FD disclosure

Feb 21

Current report 8-K Events of Feb 15

Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity, Director or officer change, or executive pay, Regulation FD disclosure, Other events

2023

Dec 31

Earnings call

Q4 2023 earnings call

Dec 11

Current report 8-K

Shareholder vote results

Nov 2

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $3.52M ▼ 46.7% Net loss $15.73M Diluted EPS $0.49 ▼ 23.4%

Oct 26

Proxy statement DEF 14A Meeting Dec 11, 2023

Proxy statement

Oct 17

Current report 8-K

Regulation FD disclosure

Oct 16

Proxy statement PRE 14A Meeting Dec 11, 2023

Proxy statement

Sep 30

Earnings call

Q3 2023 earnings call

Aug 10

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $6.15M ▼ 0.5% Net loss $16.59M Diluted EPS $0.58 ▼ 21.6%

Jul 24

Earnings call

Q2 2023 earnings call

Jul 24

Current report 8-K

Financial results, Other events

Jul 10

Registration statement S-3/A

Registration statement

Jun 29

Registration statement S-3

Registration statement

Jun 20

Current report 8-K Events of Jun 14

Entered into a material agreement, Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change

May 11

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $7.07M ▼ 12.3% Net loss $12.83M Diluted EPS $0.45 ▼ 39.2%

May 9

Current report 8-K/A Events of May 1

Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity, Charter or bylaw amendment, or fiscal year change, Other events

May 5

Current report 8-K Events of May 1

Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity, Charter or bylaw amendment, or fiscal year change, Other events

Mar 31

Earnings call

Q1 2023 earnings call

Mar 10

Current report 8-K

Regulation FD disclosure

Mar 9

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $27.66M ▲ 34.8% Net loss $62.19M Diluted EPS $2.54 ▼ 37.6%

Feb 24

Current report 8-K Events of Feb 22

Director or officer change, or executive pay, Other events

Feb 6

Earnings call

Q4 2022 earnings call

Feb 6

Current report 8-K Events of Jan 31

Financial results, Debt obligation accelerated or increased, Regulation FD disclosure

Jan 27

Current report 8-K Events of Jan 23

Director or officer change, or executive pay

Jan 13

Current report 8-K Events of Jan 9

Other events

Showing 51–100 of 163 documents

Key facts CIK 1533998 CUSIP 23725P308 13F (30d) 12 filings 6 filers Visit website Investor relations